Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma

This publication has 16 references indexed in Scilit:

• Positron emission tomographic imaging with fluorodeoxyglucose is efficacious in evaluating malignant pulmonary disease
  The Journal of Thoracic and Cardiovascular Surgery, 1999
• Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients
  The Journal of Thoracic and Cardiovascular Surgery, 1999
• Metabolic Imaging of Malignant Pleural Mesothelioma With Fluorodeoxyglucose Positron Emission Tomography
  Chest, 1998
• Positron Emission Tomography in Lung Cancer
  The Annals of Thoracic Surgery, 1998
• Preoperative Tumor Volume Is Associated With Outcome In Malignant Pleural Mesothelioma
  The Journal of Thoracic and Cardiovascular Surgery, 1998
• Improvement in Staging of Esophageal Cancer With the Addition of Positron Emission Tomography
  The Annals of Thoracic Surgery, 1997
• New methods for the staging of colorectal cancer using noninvasive techniques
  Seminars in Surgical Oncology, 1996
• The importance of surgical staging in the treatment of malignant pleural mesothelioma
  The Journal of Thoracic and Cardiovascular Surgery, 1996
• Aggressive multimodality therapy for malignant pleural mesothelioma
  The Annals of Thoracic Surgery, 1994
• Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability.
  American Journal of Roentgenology, 1992